Journal
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Volume 43, Issue 4, Pages 547-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2017.06.004
Keywords
Antiphospholipid syndrome (APS); Central nervous system (CNS); Stroke; Chorea; Psychosis; Cognitive disorder; Seizure; Sinus thrombosis
Categories
Ask authors/readers for more resources
Neurologic manifestations are common in patients with antiphospholipid antibodies and include stroke, seizures, dementia, cognitive dysfunction, chorea, migraine, psychosis, and demyelinating disease. Many of these disorders mimic their idiopathic counterparts, but treatment of antiphospholipid antibody-associated disease can be different from the treatment of central nervous system disease not associated with these antibodies. For patients with antiphospholipid antibody-associated neurologic disease, anticoagulation or immunosuppressive therapy or both may significantly improve their symptoms. Thus, clinicians should have a high index of suspicion for antiphospholipid syndrome in the appropriate clinical context.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available